ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
Dow Jones
44,296.51
0.97%
Brent Oil
74.65
0.00%
Bitcoin
97,483.46
-1.56%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. PureTech Health PLC (PRTC) Quote

PureTech Health PLC

PureTech Health PLC (PRTC)

Puretech Health Plc
22.55
0.77
(3.54%)
Closed November 23 4:00PM
Delayed by 15 minutes
22.55
0.00
(0.00%)
After Hours: 5:16PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
22.55
Bid
19.54
Ask
24.11
Volume
9,794
21.41 Day's Range 23.50
0.00 52 Week Range 0.00
Market Cap
3.531B
Previous Close
21.78
Open
21.55
Last Trade
1
@
22.5
Last Trade Time
Financial Volume
$ 217,696
VWAP
22.2275
Average Volume (3m)
-
Shares Outstanding
156,600,000
Dividend Yield
-
PE Ratio
-4.06
Earnings Per Share (EPS)
-0.42
Revenue
65.12M
Net Profit
-65.7M

About PureTech Health PLC

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines ... PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, neurological & neuropsychological disorders, among others. It operates in following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of society's healthcare needs. Show more

Sector
Home Health Care Services
Industry
Home Health Care Services
Website
www.puretechhealth.com
Headquarters
London, Gbr
Founded
-
PureTech Health PLC is listed in the Home Health Care Services sector of the NASDAQ with ticker PRTC. The last closing price for PureTech Health was $21.78. Over the last year, PureTech Health shares have traded in a share price range of $ 0.00 to $ 0.00.

PureTech Health currently has 156,600,000 shares outstanding. The market capitalization of PureTech Health is $3.41 billion. PureTech Health has a price to earnings ratio (PE ratio) of -4.06.

Ask ADVFN Intelligence (AI)

PRTC Latest News

More News

PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors

Lead Independent Director at Microsoft and former Group Worldwide Chair for Johnson & Johnson brings extensive experience in life sciences innovation, governance and operations PureTech...

November 20 2024
Business Wire

PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer

Former ImmunoGen CFO will join Seaport to steer capital financing strategy, accounting, FP&A and investor relations PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the...

November 05 2024
Business Wire

PureTech to Present at Two Upcoming Investor Conferences

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today...

October 30 2024
Business Wire

PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

Financing led by General Atlantic with participation from other top tier investors Proceeds will support key clinical milestones in Seaport’s pipeline of first and best-in-class neuropsychiatric...

October 21 2024
Business Wire

PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting

IPF patient survey provides new insights into disease burden and patient experience one decade after the approval of the first antifibrotics for IPF Clinical abstract reviews the ability of...

October 09 2024
Business Wire

PureTech to Present at CHEST 2024 Annual Meeting

Three presentations inform clinical, commercial and patient engagement strategies for LYT-100 for the treatment of idiopathic pulmonary fibrosis (IPF) Topline data from the Phase 2b ELEVATE IPF...

October 01 2024
Business Wire

PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

Milestone triggers payments to PureTech totaling $29 million under agreements with Royalty Pharma and PureTech’s Founded Entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb in...

September 27 2024
Business Wire

PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefit VCAR33ALLO demonstrates encouraging biomarker data at lowest dose New asset VADC45 with...

September 06 2024
Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

August 28 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

August 28 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
$ 8.26
(89.02%)
2.03M
XCURExicure Inc
$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
$ 0.0201
(-0.50%)
415.87M
NVDANVIDIA Corporation
$ 141.95
(-3.22%)
229.93M
SMCISuper Micro Computer Inc
$ 33.15
(11.62%)
155.43M
VRPXVirpax Pharmaceuticals Inc
$ 0.5501
(-6.72%)
154.17M
SOUNSoundHound AI Inc
$ 8.24
(18.05%)
103.6M

Discussion

View Full Feed
dstock07734 dstock07734 3 minutes ago
Does the trial target a specific subtype of rectal cancer which falls into the category of hot tumor?

PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
https://www.nejm.org/doi/full/10.1056/NEJMoa2201445


Approximately 15% of CRCs
MSI
Hosai Hosai 4 minutes ago
In pointing out the disruption to SR1 pathway (as seen in Sertraline inverse agonism) leads to negative outcomes in learning and plasticity - especially in the hippocampus it would seemingly indirectly suppose a SR1 agonist.
Obv this is Nature too so a very respected journal.
AVXL
georgie18 georgie18 5 minutes ago
What you cannot do with your 1 share of Tesla is improve the efficiency of cross-border payments...Which is the backbone of XRP...BTW...I do not need to know you have 3000 shares of Tesla...just like you don't need to know that I own 2 million shares of XRP...🥳
XRPUSD
SCAMBUSTERKING SCAMBUSTERKING 5 minutes ago
She gets it. He can issue himself as many shares as he likes and because of the illegal 3a10 and an idiot TA he can deposit and dump limitless amounts of shares no matter how much retail loses like he is doing 24/7 with SONG. There is nothing you can do about it... but I can.
BCAP
tdbowieknife tdbowieknife 5 minutes ago
Jake says one thing and does another.



..


Buyer Beware
Pump and dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG


.
BCAP
JJ8 JJ8 6 minutes ago
How did you know all this?
DIS
Penny Stocks 2.0 Penny Stocks 2.0 6 minutes ago
Share StructureMarket Cap
$6,169,659
11/22/2024

Authorized Shares
2,500,000,000
11/07/2024

Outstanding Shares
1,285,345,549
11/07/2024

Restricted
507,101,398
11/07/2024

Unrestricted
SFIO
CountOfMeltedCrisco CountOfMeltedCrisco 6 minutes ago
It is... and it isn't.
It is.... to the extent that what they're
doing with this recent bit of news is
providing "goods and services" to an
end-user who is a crypto miner.
It isn't.... to the extent that their core
business is O&G. So pick and choose.
AUNXF
laraz5 laraz5 7 minutes ago
Ok, this content in which I'm replying too States that at .13 "shares were cheap"?

Cheaper than now?

That was April 21 at All time Highs?

What storm were you referencing when you said calm before storm and shares were cheap?

Was it the stor
XCRT
Bountiful_Harvest Bountiful_Harvest 9 minutes ago
Union Pacific - Growing Dividends. Watching for now...
https://api.wsj.net/api/kaavio/charts/big.chart?nosettings=1&symb=UNP&uf=0&type=2&size=2&sid=5067&style=320&freq=1&entitlementtoken=0c33378313484ba9b46b8e24ded87dd6&time=8&rand=424991640&compidx=&ma=0&maval=9&lf=1&lf2=0&lf3=0&height=335&w
UNP
KILLAZILLA KILLAZILLA 10 minutes ago
ONLY PLACE THAT POS SHORT BUS IS GOING IS OFF THE CLIFF....WITH THE NAIVE RETAIL THAT BELIEVES THE LIES!!!!
WDLF
12x 12x 10 minutes ago
The BOD has taken several actions since the 2022 CTAD fallout. Removing CM's Chair title is one significant step, along with hiring and promoting senior management. A key move was bringing on Dr. Lopez-Talavera as head of R&D. Notably, he has been featured in every company PR since his hiring, makin
AVXL
BlazingStocks BlazingStocks 11 minutes ago
$ILLR Article November 21, 2024

TRILLER GROUP HIRES EX-TIKTOK EXEC SEAN KIM AS CEO FOR ITS APP, VOWS TO BECOME ‘ULTIMATE DESTINATION FOR CREATORS, FANS’
https://www.musicbusinessworldwide.com/triller-group-hires-ex-tiktok-exec-sean-kim-as-ceo-for-its-app-vows-to-become-ultimate
ILLR
TrendTrade2016 TrendTrade2016 12 minutes ago
THE BUZZ IS BUZZING AND A FEEDING IS TAKING PLACE
BZFD
quester614 quester614 13 minutes ago
BTW we see Carran Schneider was in Aegea he is also in the Galleon Quest team. When did SP say he meet Duffy??? About the same time all this was going on. WHAT was and IS his involvement in all this today.Didn't he have a lot of info about CTT ?????
Can't wait to hear his BS about this new fi
XERI
Miamifl Miamifl 13 minutes ago
This may help us a little:

" style="font-size: 1em"Trump on Friday nominated Dr. Marty Makary, a pancreatic surgeon at Johns Hopkins University, as commissioner of the Food and Drug Administration."
BIEL
Filterthenoise Filterthenoise 13 minutes ago
HO HO HO
RNVA
Ayock Ayock 14 minutes ago

ProfitChaser ProfitChaser 14 minutes ago
Sweet. Should be a nice one as this company doesn't put out fluff Prs or dilute
KRTL
Spuds McKenz66 Spuds McKenz66 15 minutes ago
AH hit up 38% hod , Michael Burry is buying Chinese stocks and dumping US stocks MLGO
MLGO
Monksdream Monksdream 15 minutes ago
I could do the same thing by selling 1 share of the 3000 shares I own of Tesla and buy a pick up truck load of Snickers using my debi card
Maybe this XRP thing is onto something when it comes making conversions to fiat currency much easier
XRPUSD
rbl100 rbl100 16 minutes ago
Disney now needs $1 Billion to recoup from the mess created by their star. Ooops.
DIS
JettaR JettaR 16 minutes ago

All the paid pumpers and heavy posting has helped $CBDW SO MUCH. Check the 6 month chart. 
CBDW
vinmantoo vinmantoo 16 minutes ago
Wait until RFK jr opens his mouth again to spout another round of anti/vaccine nonsense.
Omar8 Omar8 17 minutes ago
Rocketed,



Excellent video....

Waiting on that assay news....should be soon
PVGDF

Your Recent History

NASDAQ
PRTC
PureTech Health
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved